Analyst Ratings For Syneos Health (NASDAQ:SYNH)

.

Some recent analyst ratings include

• 2/23/2018-Wells Fargo & Co Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
• 1/4/2018-Credit Suisse Group Reiterated Rating of Buy.
• 1/4/2018-KeyCorp Reiterated Rating of Buy.
• 12/11/2017-Barclays initiated coverage with a Equal Weight rating.

Recent Insider Trading Activity For Syneos Health (NASDAQ:SYNH)
Syneos Health (NASDAQ:SYNH) has insider ownership of 0.24% and institutional ownership of 96.41%.

• On 1/22/2018 Christopher L Gaenzle, CAO, sold 1,470 with an average share price of $41.00 per share and the total transaction amounting to $60,270.00.
• On 9/18/2017 Alistair Macdonald, CEO, sold 2,348 with an average share price of $54.60 per share and the total transaction amounting to $128,200.80.
• On 9/18/2017 Christopher L Gaenzle, CAO, sold 4,682 with an average share price of $54.56 per share and the total transaction amounting to $255,449.92.
• On 9/18/2017 Gregory S Rush, CFO, sold 9,703 with an average share price of $54.48 per share and the total transaction amounting to $528,619.44.
• On 9/1/2017 Christopher L Gaenzle, CAO, sold 42,601 with an average share price of $58.67 per share and the total transaction amounting to $2,499,400.67.
• On 9/1/2017 Gregory S Rush, CFO, sold 88,739 with an average share price of $58.99 per share and the total transaction amounting to $5,234,713.61.
• On 8/30/2017 Gregory S Rush, CFO, sold 41,420 with an average share price of $58.26 per share and the total transaction amounting to $2,413,129.20.

Recent Trading Activity for Syneos Health (NASDAQ:SYNH)
Shares of Syneos Health closed the previous trading session at with 33.25 shares trading hands.